Vascular growth factors and lymphangiogenesis

被引:311
作者
Jussila, L
Alitalo, K
机构
[1] Univ Helsinki, Haartman Inst, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Biomedicum Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland
关键词
D O I
10.1152/physrev.00005.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Blood and lymphatic vessels develop in a parallel, but independent manner, and together form the circulatory system allowing the passage of fluid and delivering molecules within the body. Although the lymphatic vessels were discovered already 300 years ago, at the same time as the blood circulation was described, the lymphatic system has remained relatively neglected until recently. This is in part due to the difficulties in recognizing these vessels in tissues because of a lack of specific markers. Over the past few years, several molecules expressed specifically in the lymphatic endothelial cells have been characterized, and knowledge about the lymphatic system has started to accumulate again. The vascular endothelial growth factor (VEGF) family of growth factors and receptors is involved in the development and growth of the vascular endothelial system. Two of its family members, VEGF-C and VEGF-D, regulate the lymphatic endothelial cells via their receptor VEGFR-3. With the aid of these molecules, lymphatic endothelial cells can be isolated and cultured, allowing detailed studies of the molecular properties of these cells. Also the role of the lymphatic endothelium in immune responses and certain pathological conditions can be studied in more detail, as the blood and lymphatic vessels seem to be involved in many diseases in a coordinated manner. Discoveries made so far will be helpful in the diagnosis of certain vascular tumors, in the design of specific treatments for lymphedema, and in the prevention of metastatic tumor spread via the lymphatic system.
引用
收藏
页码:673 / 700
页数:28
相关论文
共 239 条
  • [1] Aase K, 1999, DEV DYNAM, V215, P12, DOI 10.1002/(SICI)1097-0177(199905)215:1<12::AID-DVDY3>3.0.CO
  • [2] 2-N
  • [3] Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect
    Aase, K
    von Euler, G
    Li, X
    Pontén, A
    Thorén, P
    Cao, R
    Cao, Y
    Olofsson, B
    Gebre-Medhin, S
    Pekny, M
    Alitalo, K
    Betsholtz, C
    Eriksson, U
    [J]. CIRCULATION, 2001, 104 (03) : 358 - 364
  • [4] Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO
  • [5] 2-G
  • [6] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [7] Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
    Adams, RH
    Wilkinson, GA
    Weiss, C
    Diella, F
    Gale, NW
    Deutsch, U
    Risau, W
    Klein, R
    [J]. GENES & DEVELOPMENT, 1999, 13 (03) : 295 - 306
  • [8] Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
    Akagi, K
    Ikeda, Y
    Miyazaki, M
    Abe, T
    Kinoshita, J
    Maehara, Y
    Sugimachi, K
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (07) : 887 - 891
  • [9] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY
    ALON, T
    HEMO, I
    ITIN, A
    PEER, J
    STONE, J
    KESHET, E
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1024 - 1028
  • [10] [Anonymous], 1999, PATHOLOGY MOUSE